Clinical Trial Update: Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating augmentation with amisulpride in patients with schizophrenia unresponsive to clozapine; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Amisulpride (amisulpride)

Snippet

Sponsor: Imperial College London | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED